JERSEY CITY, N.J., Jan. 6 -- The following is being issued by M.H. Meyerson & Co., Inc., a member of the National Association of Securities Dealers, CRD number 540:
M.H. Meyerson & Co., Inc. announced coverage has been initiated for American Biogenetic Sciences, Inc. (Nasdaq: MABXA - news), which is rated a ``BUY.''
A research report is available, which was prepared by Dr. Jeffrey H. Berg of M.H. Meyerson & Co., Inc., 525 Washington Blvd., Jersey City, New Jersey 07310. For more information, contact the Institutional Department at 201-459-9440 or 800-422-4114; web site: http://www.mhmeyerson.com.
SOURCE: M.H. Meyerson & Co., Inc.